Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter, Randomized, Parallel-Controlled, Subject-Blinded, Evaluator-Blinded, Non-Inferiority Clinical Trial to Evaluate the Efficacy and Safety of PEGDE-crosslinked Hyaluronic Acid Hydrogels for the Correction of Midface Volume Deficiency and/or Midface Contour Deficiency

NCT07359079 is registered in ClinicalTrials.gov with Chongqing Jinsaixing Medical Technology Co., Ltd as lead sponsor.

NCT NCT07359079
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07359079 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter, Randomized, Parallel-Controlled, Subject-Blinded, Evaluator-Blinded, Non-Inferiority Clinical Trial to Evaluate the Efficacy and Safety of PEGDE-crosslinked Hyaluronic Acid Hydrogels for the Correction of Midface Volume Deficiency and/or Midface Contour Deficiency
Lead sponsor
Chongqing Jinsaixing Medical Technology Co., Ltd
Phase
Not applicable
Overall status
Active, not recruiting
Start date
March 19, 2025
Completion date
February 27, 2027
Enrollment
356 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

the correction of midface volume deficiency and/or midface contour deficiency